Establishment Labs Holdings Inc.(ESTA)Earnings, Financials & Key RatiosEstablishment Labs Holdings Inc. (ESTA) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's reliance on external funding is underscored by a 2026Q1 net margin of -22.3% and a precarious cash position of $68.1 million that necessitates further scrutiny of long-term liquidity.
Establishment Labs Holdings Inc. (ESTA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Establishment Labs Holdings Inc. (ESTA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.40vs $0.35-12.7% | $60Mvs $57M+4.3% |
| Q1 2026 | Feb 24, 2026 | $0.09vs $0.21+58.1% | $65Mvs $64M+1.3% |
| Q4 2025 | Nov 5, 2025 | $0.38vs $0.54+29.6% | $54Mvs $64M-15.7% |
| Q3 2025 | Aug 7, 2025 | $0.57vs $0.54-5.6% | $51Mvs $52M-2.2% |
Recent stock market news and headlines for Establishment Labs Holdings Inc. (ESTA)
JW Asset Management sold 90,533 shares between May 26 and May 28, 2026, generating a transaction value of ~$6.64 million at a weighted average price of around $73.31 per share. The transaction represented 3.04% of the insider's total indirect holdings, reducing indirect ownership from ~2.98 million to ~2.89 million shares.
NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced today the appointment of Taylor Harris to its Board of Directors. Mr. Harris brings more than 25 years of experience in corporate finance, executive leadership and board governance across healthcare, medical technology and life sciences companies. He currently serves on t.
NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will be added as a member of the US small-cap Russell 2000® Index, effective when the US market opens on June 29th as part of the 2026 Russell indexes reconstitution. Membership in the Russell 2000® Index, which remains in place for half a year beginning 2026, is based on membershi.
Key metrics vs top competitors for Establishment Labs Holdings Inc. (ESTA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $89.23 | $2.62B | -51.88 | 27.14% | -24.19% | -133.25% | — | |
| $181.49 | $13B | 32.12 | 0.9% | 10.5% | 10.7% | — | |
| $14.68 | $930.11M | 10.27 | -6.16% | 23.27% | 13.28% | — | |
| $6.34 | $79.21M | -25.36 | 14.52% | -9.05% | -70.95% | — | |
| $8.86 | $1.34B | -9.23 | 24.95% | -21.07% | -443.09% | — | |
| $15.78 | $1.8B | -12.93 | 8.28% | -25.66% | -50.82% | — |
Establishment Labs Holdings Inc. (ESTA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Establishment Labs Holdings Inc. (ESTA) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 6, 2026·SEC
Apr 30, 2026·SEC
Feb 24, 2026·SEC
Get notified when ESTA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Establishment Labs Holdings Inc. (ESTA) stock FAQ — growth, dividends, profitability & financials explained
Establishment Labs Holdings Inc. (ESTA) reported $229.6M in revenue for fiscal year 2025. This represents a 1059% increase from $19.8M in 2016.
Establishment Labs Holdings Inc. (ESTA) grew revenue by 27.1% over the past year. This is strong growth.
Establishment Labs Holdings Inc. (ESTA) reported a net loss of $43.7M for fiscal year 2025.
Establishment Labs Holdings Inc. (ESTA) has a return on equity (ROE) of -133.3%. Negative ROE indicates the company is unprofitable.
Establishment Labs Holdings Inc. (ESTA) had negative free cash flow of $42.1M in fiscal year 2025, likely due to heavy capital investments.
